Litcius/Paper detail

Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

Dani Cohen, Jacob Atsmon, Cécile Artaud, Shiri Meron-Sudai, Marie‐Lise Gougeon, Anya Bialik, Sophy Goren, Valeria Asato, Ortal Ariel-Cohen, Arava Reizis, Alexandra Dorman, Carla W G Hoitink, Janny Westdijk, Shai Ashkenazi, Philippe Sansonetti, Laurence A. Mulard, Armelle Phalipon

2020The Lancet Infectious Diseases94 citationsDOI

Topics & Concepts

MedicineImmunogenicityPlaceboPopulationShigella flexneriImmunologyInternal medicineAdverse effectAntibodyBiologyEscherichia coliEnvironmental healthGenePathologyBiochemistryAlternative medicineEscherichia coli research studiesViral gastroenteritis research and epidemiologyInfant Nutrition and Health